BioHarvest begins Tel Aviv dual listing Sept. 8

BIOHARVEST SCIENCES INC.

Rhea-AI Filing Summary

BIOHARVEST SCIENCES INC. (BHST) reported that its common shares have been registered for trading on the Tel Aviv Stock Exchange (TASE), creating a dual listing alongside its existing listing on the Nasdaq Capital Market. The company’s common shares began trading on the TASE on September 8, 2026.

Under the TASE registration, the company listed 22,667,842 outstanding common shares, up to 4,516,021 common shares reserved for its equity incentive plan (including options and restricted share units), and 610,742 common shares issuable upon exercise of investor warrants. The shares trade on TASE under the English symbol BHST and an alternative Hebrew symbol. The company states that all future EDGAR submissions will also be filed on the Israeli MAGNA Disclosure System.

Key Figures

Outstanding common shares registered on TASE: 22,667,842 shares Equity incentive plan shares covered: 4,516,021 shares Options under equity incentive plan: 2,564,876 options +4 more

7 metrics

Outstanding common shares registered on TASE 22,667,842 shares All outstanding common shares included in the TASE dual listing request

Equity incentive plan shares covered 4,516,021 shares Maximum common shares available under equity incentive plan included in TASE registration

Options under equity incentive plan 2,564,876 options Options to purchase common shares currently outstanding under the company’s equity incentive plan

Restricted share units outstanding 269,521 RSUs Restricted share units currently outstanding under the equity incentive plan

Shares remaining for future grants 1,681,624 shares Common shares still available for future grants under the equity incentive plan

Warrant shares covered 610,742 shares Common shares issuable upon exercise of 610,742 warrants included in the TASE registration

TASE trading start date September 8, 2026 Date BHST common shares began trading on the Tel Aviv Stock Exchange

Key Terms

dual-listed, Tel Aviv Stock Exchange (TASE), equity incentive plan, restricted share units, +2 more

6 terms

dual-listed market

"to become dual-listed for trade on both the Nasdaq and TASE markets"

Tel Aviv Stock Exchange (TASE) market

"register its common shares ... on the Tel Aviv Stock Exchange (TASE)"

equity incentive plan financial

"available for future issuance ... pursuant to the Company's equity incentive plan"

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

restricted share units financial

"2,564,876 options to purchase Common Shares and 269,521 restricted shares units"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

warrants financial

"610,742 Common Shares issuable upon exercise of 610,742 warrants granted to investors"

Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.

MAGNA Disclosure System regulatory

"All future EDGAR filings will simultaneously be filed on MAGNA Disclosure System"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What material change did BIOHARVEST SCIENCES INC. (BHST) report in this Form 6-K?

BHST reported that its common shares were registered on the Tel Aviv Stock Exchange, creating a dual listing on Nasdaq and TASE. Trading on the TASE began on September 8, 2026, following a news release dated September 3, 2026.

How many BIOHARVEST SCIENCES INC. (BHST) common shares are registered for trading on the TASE?

The TASE registration covers 22,667,842 outstanding common shares, plus up to 4,516,021 common shares related to the equity incentive plan and 610,742 common shares issuable upon exercise of warrants, as described in the material change report.

Does the BIOHARVEST SCIENCES INC. (BHST) TASE listing include equity incentive plan shares?

Yes. The TASE registration includes up to 4,516,021 common shares tied to BHST’s equity incentive plan, comprising 2,564,876 options, 269,521 restricted share units, and 1,681,624 shares remaining available for future grants.

Are BIOHARVEST SCIENCES INC. (BHST) warrant shares also covered by the TASE registration?

Yes. The registration includes 610,742 common shares issuable upon exercise of 610,742 warrants granted to investors, allowing those warrant shares to be traded on the Tel Aviv Stock Exchange once exercised.

What disclosure systems will BIOHARVEST SCIENCES INC. (BHST) use going forward?

BHST states that all future EDGAR filings will simultaneously be filed on the Israeli MAGNA Disclosure System, aligning its U.S. and Israeli public disclosure for investors in both markets.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/15/2026 - 05:07 PM Accepted by SEC EDGAR 09/15/2026 - 05:07 PM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of September 2026

Commission file number: 001-42389

BIOHARVEST SCIENCES INC.

(Exact name of Registrant as specified in its charter)

Not applicable

(Translation of Registrant’s name into English)

1140-625 Howe Street, Vancouver, British Columbia V6C 2T6, Canada

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

☐ Form 20-F ☒ Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

SUBMITTED HEREWITH

Exhibits:

Exhibit	Description
99.1	Material Change Report dated September 15, 2026

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	BIOHARVEST SCIENCES INC.
	(Registrant)
Date: September 15, 2026	/s/ David Ryan
	Name: David Ryan
	Title: Vice-President, Investor Relations & Secretary

FORM 51-102F3

MATERIAL CHANGE REPORT

Item 1.Name and Address of Company 

BIOHARVEST SCIENCES INC.

Suite 1140 – 625 Howe Street

Vancouver, BC, V6C 2T6

(the “Company” or “BioHarvest”)

Item 2.Date of Material Change 

September 8, 2026

Item 3.News Release 

The news release (the “News Release”) was issued on September 3, 2026 and disseminated by Newsfile Corp.

Item 4.Summary of Material Change 

The Company announced its intention to register its common shares without par value (the “Common Shares”) on the Tel Aviv Stock Exchange (TASE) and to become dual-listed for trade on both the Nasdaq and TASE markets. The Company’s Common Shares began trading on the TASE on September 8, 2026.

Item 5.Full Description of Material Change 

On September 3, 2026, Company announced its intention to register all its outstanding Common Shares on the Tel Aviv Stock Exchange (TASE) and to become dual-listed for trade on both the Nasdaq and TASE markets.  

The Company’s Common Shares began trading on the TASE on September 8, 2026.

Per the filed registration documents, the Company requested to register Common Shares for dual listing on the TASE, including:

(1) all 22,667,842 outstanding Common Shares;

(2) up to 4,516,021 Common Shares available for future issuance to officers, employees and consultants of the Company pursuant to the Company's equity incentive plan, out of which 2,564,876 options to purchase Common Shares and 269,521 restricted shares units are currently outstanding and 1,681,624 Common Shares remain available for future grants (upon exercise of options and restricted share units); and

(3) 610,742 Common Shares issuable upon exercise of 610,742 warrants granted to investors.

The Common Shares are listed for trading in the United States on the Nasdaq Capital Market and as of September 8, 2026 are also listed for trading on the TASE, under the English symbol BHST and the alternative Hebrew symbol "".  

All future EDGAR filings will simultaneously be filed on MAGNA Disclosure System.

Item 6.Reliance on Subsection 7.1(2) of National Instrument 51-102 

Not applicable.

Item 7.Omitted Information 

None.

Item 8.Executive Officer 

For further information, please contact:

David Ryan

Secretary and VP, Investor Relations

604 622-1187

Item 9.Date of Report 

September 15, 2026.

Filing Exhibits & Attachments

1 document

Press Releases

• EX-99.1 MATERIAL CHANGE REPORT DATED SEPTEMBER 15, 2026 10.1 KB